glp-1 receptor agonist nausea diarrhea management GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment can a glp 1 cause

2024;44:NP809NP818

Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: a new mechanism linking berberine to insulin resistance improvement

For patients considering or currently using GLP-1 therapy, understanding these interactions is critical to safety and treatment success

Having compassion and empathy for a person whose experience is different from your own can go a long way to creating a safe space for us all to live, with the bodies and history that we have

There are also no FDA-approved drug products containing berberine, the agency adds

The side effect comparison between semaglutide and tirzepatide is a relevant clinical question during a transition, but testing outcomes are identical: neither compound is detectable on standard employment or clinical drug panels